Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RABEP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MIR3658 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBQLN4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C1orf21 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SVIL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBAP2L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AFF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IPO9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM20B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MDM4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OCIAD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SYNE3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
G3BP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WDR26 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMG7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EIF2D - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SUMF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAB40B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VAMP4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARFIP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on